Hematology

The authors have previously reported their Phase I clinical trial regarding a combination treatment of CD19- and CD22-specific chimeric…

There is a trend towards higher frequency of high-risk cytogenetic aberrations in patients with NRAS gene mutations compared to patients with KRAS gene mutations. Read more.

The ongoing large-scale screen of non-M41 variants in patients suspected of HMs continues to detect both recurrent and novel non-M41 variants. The patients harbouring non-M41 variants are rare but may be more malignant.

Patient blood management encompasses all aspects of the transfusion decision-making process, beginning with the initial patient evaluation and continuing through clinical management.

Classical Hodgkin lymphoma, acute promyelocytic leukaemia, post-transplant relapse, massive transfusion, and many more essential topics in haematology were explored in several unique and insightful abstracts presented at the European Hematology Association (EHA) 2023 Congress.

The following highlights focus on several insightful and innovative abstracts at the European Hematology Association (EHA) 2022 hybrid…

Presenting at the European Hematology Association (EHA) 2022 Congress, Peter Borchmann from the University of Cologne, Germany…

Patients with haematologic malignancies appear to have a greater risk of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection and severe disease due to myelosuppression.